Cargando…

More breast cancer genes?

A new gene associated with a high risk of breast cancer, termed BRCAX, may exist on chromosome 13q. Tumours from multicase Nordic breast cancer families, in which mutations in BRCA1 and BRCA2 had been excluded, were analyzed using comparative genomic hybridization in order to identify a region of in...

Descripción completa

Detalles Bibliográficos
Autor principal: Hopper, John L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2001
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC138680/
https://www.ncbi.nlm.nih.gov/pubmed/11305950
http://dx.doi.org/10.1186/bcr290
_version_ 1782120472486346752
author Hopper, John L
author_facet Hopper, John L
author_sort Hopper, John L
collection PubMed
description A new gene associated with a high risk of breast cancer, termed BRCAX, may exist on chromosome 13q. Tumours from multicase Nordic breast cancer families, in which mutations in BRCA1 and BRCA2 had been excluded, were analyzed using comparative genomic hybridization in order to identify a region of interest, which was apparently confirmed and refined using linkage analysis on an independent sample. The present commentary discusses this work. It also asks why there should exist genetic variants associated with susceptibility to breast cancer other than mutations in BRCA1 and BRCA2, and what might be their modes of inheritance, allele frequencies and risks. Replication studies will be needed to clarify whether there really is a tumour suppressor gene other than BRCA2 on chromosome 13q.
format Text
id pubmed-138680
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-1386802003-02-27 More breast cancer genes? Hopper, John L Breast Cancer Res Commentary A new gene associated with a high risk of breast cancer, termed BRCAX, may exist on chromosome 13q. Tumours from multicase Nordic breast cancer families, in which mutations in BRCA1 and BRCA2 had been excluded, were analyzed using comparative genomic hybridization in order to identify a region of interest, which was apparently confirmed and refined using linkage analysis on an independent sample. The present commentary discusses this work. It also asks why there should exist genetic variants associated with susceptibility to breast cancer other than mutations in BRCA1 and BRCA2, and what might be their modes of inheritance, allele frequencies and risks. Replication studies will be needed to clarify whether there really is a tumour suppressor gene other than BRCA2 on chromosome 13q. BioMed Central 2001 2001-03-29 /pmc/articles/PMC138680/ /pubmed/11305950 http://dx.doi.org/10.1186/bcr290 Text en Copyright © 2001 BioMed Central Ltd
spellingShingle Commentary
Hopper, John L
More breast cancer genes?
title More breast cancer genes?
title_full More breast cancer genes?
title_fullStr More breast cancer genes?
title_full_unstemmed More breast cancer genes?
title_short More breast cancer genes?
title_sort more breast cancer genes?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC138680/
https://www.ncbi.nlm.nih.gov/pubmed/11305950
http://dx.doi.org/10.1186/bcr290
work_keys_str_mv AT hopperjohnl morebreastcancergenes